Compare midazolam and propofol for prevention of emergence agitation in children

Comparison of midazolam with propofol given at the end of surgery for prevention of emergence delirium in children undergoing infraumbilical abdominal surgery - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064208

Enrollment

Registered

2024-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Inj Midazolam or Inj propofol: At the end of surgery, single dose of intravenous midazolam(0.03mg/kg) or intravenous propofol(1mg/kg) will be given to the patients. Control Intervention

Eligibility

Inclusion criteria

Inclusion criteria: ASA class 1&2

Exclusion criteria

Exclusion criteria: Children with developmental delay, psychological and neurological disorders, abnormal airway, respiratory disease and cardiovascular diseases

Design outcomes

Primary

Measure	Time frame
Incidence of emergence delirium using Paediatric Anaesthesia Emergence Delirium(PAED) scaleTimepoint: At baseline	—

Secondary

Measure	Time frame
Recovery time, Duration of sevoflurane administration, FLACCS Score in both groups, any adverse effects like nausea/vomiting,laryngospasm,desaturation,bronchospasmTimepoint: FLACCS score measured at baseline	—

Countries

India

Contacts

Public ContactDr.Nang Sujali Choupoo

ABVIMS & DR RAM MANOHAR LOHIA HOSPITAL ,NEW DELHI

sujalichoupoo@yahoo.com8587887234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026